When m6A tags were added to VCAN's RNA, the cancer became more aggressive and more likely to metastasize. Targeting these modifications could offer a new way to slow down or stop the disease.

"m6A is interesting for science because this modification is often altered in people who suffer from metabolic disorders, cancer or heart disease," explains bioinformatician Kathi Zarnack.

The Ischemic Heart Disease Epitranscriptomics and Biomarkers (IHD-EPITRAN) study hypothesis states that the pathological features of IHD are mirrored in circulating cellular or extracellular ...